Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,785 public trials 653 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity trial results

Completed

Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype

NCT04719832

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Encinitas, California, United States
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Pasadena, California, United States
  • GSK Investigational Site Rancho Cucamonga, California, United States
View all 123 locations
View Trial Details
Completed

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age

NCT03211247

Conditions
Food Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate, +4 more
Locations
  • University of Arizona Health Science Tucson, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • University of California School of Medicine Los Angeles, California, United States
  • University of California, Rady Children's Hospital San Diego, California, United States
View all 51 locations
View Trial Details
Completed

A Study of Lanadelumab (SHP643) in Chinese Participants With Hereditary Angioedema (HAE)

NCT05460325

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei, China
  • Yantai Yuhuangding Hospital Yantai, Shandong, China
  • Peking Union Medical College Hospital Beijing, China
View Trial Details
Completed

Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma

NCT04276233

Conditions
Asthma, Bronchial Diseases, Eosinophilia, +12 more
Locations
  • GSK Investigational Site Ahmedabad, India
  • GSK Investigational Site Ahmedabad, India
  • GSK Investigational Site Byculla Mumbai, India
  • GSK Investigational Site Hyderabad, India
View all 14 locations
View Trial Details
Completed

Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible Urticaria

NCT06050928

Conditions
Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +10 more
Locations
  • Advanced Clinical Research Institute Tampa, Florida, United States
  • Treasure Valley Medical Research Boise, Idaho, United States
  • Allergy & Asthma Specialists, P.S.C. Owensboro, Kentucky, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 15 locations
View Trial Details

Related conditions